Valacyclovir Tablets (VA-22-00022674)   3

Background
The solicitation is issued by the Department of Veterans Affairs (VA) and the Department of Defense (DOD) Pharmaceutical Prime Vendor Programs. The purpose is to establish a supply source for pharmaceutical products to ensure availability and consistency of product for nationwide usage and to obtain volume-based, committed-use pricing.

Work Details
The contract is for the supply of Valacyclovir HCL Tablets. One award will be made in the aggregate for line items 1, 2, 3, and 4. Offerors must submit prices for the base year and all four one-year options for all line items. Prices offered shall not exceed two decimal places.
Offered prices must include an 11 digit NDC number for each offered drug that is unique to the Offeror's company as outlined in scope of contract. If the offeror is a distributor, the NDC number must be unique to the distributor.

Period of Performance
The contract effective date will be determined at the time of contract award. The implementation period will be a maximum of 60 calendar days, and the ordering period for the base year will be in effect for one year.

Place of Performance
Products will be ordered by Government Prime Vendor contractors and delivered to various facilities including VA facilities, DOD Pharmaceutical Prime Vendor Program participants, Indian Health Service facilities, Bureau of Prisons facilities, Captain James A. Lovell Federal Health Care Center (FHCC), and State Veteran Homes.